{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,9,4]],"date-time":"2023-09-04T11:00:27Z","timestamp":1693825227480},"reference-count":20,"publisher":"Japanese Society of Internal Medicine","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2020,6,15]]},"DOI":"10.2169\/internalmedicine.4190-19","type":"journal-article","created":{"date-parts":[[2020,6,14]],"date-time":"2020-06-14T22:05:09Z","timestamp":1592172309000},"page":"1519-1524","source":"Crossref","is-referenced-by-count":3,"title":["Fulminant Hepatitis due to <i>de novo<\/i> Hepatitis B after Cord Blood Transplantation Rescued by Medical Treatment"],"prefix":"10.2169","volume":"59","author":[{"given":"Tomoya","family":"Sano","sequence":"first","affiliation":[{"name":"Department of Hepatology, Toranomon Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norio","family":"Akuta","sequence":"additional","affiliation":[{"name":"Department of Hepatology, Toranomon Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshiyuki","family":"Suzuki","sequence":"additional","affiliation":[{"name":"Department of Hepatology, Toranomon Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kayoko","family":"Kasuya","sequence":"additional","affiliation":[{"name":"Department of Hepatology, Toranomon Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shunichiro","family":"Fujiyama","sequence":"additional","affiliation":[{"name":"Department of Hepatology, Toranomon Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yusuke","family":"Kawamura","sequence":"additional","affiliation":[{"name":"Department of Hepatology, Toranomon Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hitomi","family":"Sezaki","sequence":"additional","affiliation":[{"name":"Department of Hepatology, Toranomon Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tetsuya","family":"Hosaka","sequence":"additional","affiliation":[{"name":"Department of Hepatology, Toranomon Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoshi","family":"Saitoh","sequence":"additional","affiliation":[{"name":"Department of Hepatology, Toranomon Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahiro","family":"Kobayashi","sequence":"additional","affiliation":[{"name":"Department of Hepatology, Toranomon Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fumitaka","family":"Suzuki","sequence":"additional","affiliation":[{"name":"Department of Hepatology, Toranomon Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariko","family":"Kobayashi","sequence":"additional","affiliation":[{"name":"Liver Research Laboratory, Toranomon Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuji","family":"Arase","sequence":"additional","affiliation":[{"name":"Department of Hepatology, Toranomon Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenji","family":"Ikeda","sequence":"additional","affiliation":[{"name":"Department of Hepatology, Toranomon Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiromitsu","family":"Kumada","sequence":"additional","affiliation":[{"name":"Department of Hepatology, Toranomon Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"publisher","unstructured":"1. Tanaka J, Kumagai J, Katayama K, et al. Sex- and age-specific carriers of hepatitis B and C virus in Japan estimated by the prevalence in the 3,485,648 first-time blood donors during 1995-2000. Intervirology 47: 32-40, 2004.","DOI":"10.1159\/000076640"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Kusumoto S, Tanaka Y, Mizokami M, et al. Reactivation of hepatitis B virus following systemic chemotherapy for malignant lymphoma. Int J Hematol 90: 13-23, 2009.","DOI":"10.1007\/s12185-009-0359-5"},{"key":"3","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0016-5085(75)80054-0","volume":"68","author":"JR Wands","year":"1975","unstructured":"3. Wands JR, Chura CM, Roll FJ, et al. Serial studies of hepatitis associated antigen and antibody in patients receiving antitumor chemotherapy for myeloproliferative and lymphoproliferative disorders. Gastroenterology 68: 105-112, 1975.","journal-title":"Gastroenterology","ISSN":"http:\/\/id.crossref.org\/issn\/0016-5085","issn-type":"print"},{"key":"4","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/0016-5085(91)90599-G","volume":"100","author":"AS Lok","year":"1991","unstructured":"4. Lok AS, Liang RH, Chiu EK, et al. Todd D. Reactivation of hepatitis B virus replication in patients receiving cytotoxic therapy. Report of a prospective study. Gastroenterology 100: 182-188, 1991.","journal-title":"Gastroenterology","ISSN":"http:\/\/id.crossref.org\/issn\/0016-5085","issn-type":"print"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Umemura T, Kiyosawa K. Fatal HBV reactivation in a subject with anti-HBs and anti-HBc. Intern Med 45: 747-748, 2006.","DOI":"10.2169\/internalmedicine.45.0158"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Nakao M, Nakayama N, Uchida Y, et al. Nationwide survey for acute liver failure and late-onset hepatic failure in Japan. J Gastroenterol 53: 752-769, 2018.","DOI":"10.1007\/s00535-017-1394-2"},{"key":"7","unstructured":"7. In: The Proceedings of the 12th Inuyama Symposium. Hepatitis type A and fulminant hepatitis. Chugai Igaku-sha, Tokyo, 1982 (in Japanese)."},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Fujiwara K, Mochida S, Matsui A, Nakayama N, Nagoshi S, Toda G. Fulminant hepatitis and late onset hepatic failure in Japan. Hepatol Res 38: 646-657, 2008.","DOI":"10.1111\/j.1872-034X.2008.00322.x"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Omata M, Ehata T, Yokosuka O, et al. Mutations in the precore region of hepatitis B virus DNA in patients with fulminant and severe hepatitis. N Engl J Med 324: 1699-1704, 1991.","DOI":"10.1056\/NEJM199106133242404"},{"key":"10","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1002\/hep.21249","volume":"44","author":"A Ozasa","year":"2006","unstructured":"10. Ozasa A, Tanaka Y, Orito E, et al. Influence of genotypes and precore mutations on fulminant or chronic outcome of acute hepatitis B virus infection. Hepatology 44: 326-334, 2006.","journal-title":"Hepatology","ISSN":"http:\/\/id.crossref.org\/issn\/0270-9139","issn-type":"print"},{"key":"11","unstructured":"11. Oketani M, Ido A, Nakayama N, et al. Etiology and prognosis of fulminant hepatitis and late-onset hepatic failure in Japan: summary of the annual nationwide survey between 2004 and 2009. Hepatol Res 43: 97-105, 2013."},{"key":"12","unstructured":"12. Fujiwara K, Yasui S, Tawada A, et al. Autoimmune fulminant liver failure in adults: experience in a Japanese center. Hepatol Res 41: 133-141, 2011."},{"key":"13","unstructured":"13. Yasui S, Fujiwara K, Haga Y, et al. Infectious complications, steroid use and timing for emergency liver transplantation in acute liver failure: Analysis in a Japanese center. J Hepatobiliary Pancreat Sci 23: 756-762, 2016."},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Fujiwara K, Abe R, Yasui S, Yokosuka O, Kato N, Oda S. High recovery rate of consciousness by high-volume filtrate hemodiafiltration for fulminant hepatitis. Hepatol Res 49: 224-231, 2019.","DOI":"10.1111\/hepr.13255"},{"key":"15","unstructured":"15. Naiki T, Nakayama N, Mochida S, et al.; Intractable Hepato-Biliary Disease Study Group supported by the Ministry of Health, Labor and Welfare of Japan. Novel scoring system as a useful model to predict the outcome of patients with acute liver failure: Application to indication criteria for liver transplantation. Hepatol Res 42: 68-75, 2012."},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Drafting Committee for Hepatitis Management Guidelines and the Japan Society of Hepatology. JSH guidelines for the management of hepatitis B virus infection. Hepatol Res 44 (Suppl): 1-58, 2014.","DOI":"10.1111\/hepr.12269"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Kimura M, Nishikawa K, Sakamaki H, Mizokami M, Kimura K. Reduced therapeutic effect of antiviral drugs in patients with hepatitis B virus reactivation after hematopoietic stem cell transplantation. Hepatol Res 48: 469-478, 2018.","DOI":"10.1111\/hepr.13044"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Onozawa M, Hashino S, Darmanin S, et al. HB vaccination in the prevention of viral reactivation in allogeneic hematopoietic stem cell transplantation recipients with previous HBV infection. Biol Blood Marrow Transplant 14: 1226-1230, 2008.","DOI":"10.1016\/j.bbmt.2008.08.007"},{"key":"19","doi-asserted-by":"publisher","unstructured":"19. Onozawa M, Hashino S, Izumiyama K, et al. Progressive disappearance of anti-hepatitis B surface antigen antibody and reverse seroconversion after allogeneic hematopoietic stem cell transplantation in patients with previous hepatitis B virus infection. Transplantation 79: 616-619, 2005.","DOI":"10.1097\/01.TP.0000151661.52601.FB"},{"key":"20","unstructured":"20. Mikulska M, Nicolini L, Signori A, et al. Hepatitis B reactivation in HBsAg-negative\/HBcAb-positive allogeneic haematopoietic stem cell transplant recipients: risk factors and outcome. Clin Microbiol Infect 20: 694-701, 2014."}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/59\/12\/59_4190-19\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,20]],"date-time":"2020-06-20T03:30:27Z","timestamp":1592623827000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/59\/12\/59_4190-19\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,15]]},"references-count":20,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.4190-19","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,15]]}}}